28 Jun 2011 Sinovac Commences Phase II Clinical Trial for EV71 Vaccine
27 Jun 2011 PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
24 Jun 2011 Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
23 Jun 2011 GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine
23 Jun 2011 Diamyd Medical: Diamyd Initiates Closure of US Phase III study
21 Jun 2011 Mayo Clinic Researchers Use Human Vaccine to Cure Prostate Cancer in Mice
21 Jun 2011 Hemispherx Biopharma's Ampligen(R) Tested in Combination With Experimental Vaccine From Leading Cancer Research Institute
21 Jun 2011 NanoBio Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study
20 Jun 2011 Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan
20 Jun 2011 FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
16 Jun 2011 Novartis application for expanded Menveo(R) indication from 2 months of age accepted for review by FDA
16 Jun 2011 Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore
16 Jun 2011 BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine
14 Jun 2011 Arecor and GSK Form Collaboration to Advance New Vaccines
14 Jun 2011 GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
13 Jun 2011 Circassia's Rapid Four-Dose ToleroMune Treatment Maintains Significant Reduction in Allergy Symptoms During 12-Month Follow-up
10 Jun 2011 The Juvenile Diabetes Research Foundation and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes
09 Jun 2011 ImmunoCellular Therapeutics Ltd. Expands Phase II Trial of ICT-107
09 Jun 2011 Isconova enters into adjuvant license agreement with Crucell
08 Jun 2011 Medicago reports positive U.S. clinical trial results for its H1N1 / seasonal influenza vaccine
08 Jun 2011 Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
08 Jun 2011 RXi Pharmaceuticals Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at ASCO
06 Jun 2011 Vaxart Begins First Oral Vaccine Clinical Trial
06 Jun 2011 Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has begun dosing volunteers in a Phase I clinical trial
06 Jun 2011 BioSante Pharmaceuticals Announces Lifting of Clinical Hold on GVAX Prostate Cancer Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up